Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolidine-derived beta 3 adrenergic receptor agonists

Pyrrolidine-derived beta 3 adrenergic receptor agonists

US Patent 8618144 · Granted Dec 31, 2013

Estimated economic value: $40,993,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems, methods and devices for peripheral neuromodulation2025
Systems and methods for mechanogenetic functional ultrasound imaging2024
Systems, methods and devices for peripheral neuromodulation2024
Systems, methods and devices for peripheral neuromodulation of the leg2024
Systems, methods and devices for peripheral neuromodulation for treating disease2022
Systems, methods and devices for peripheral neuromodulation for treating disease2022
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists2021
Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors2020
Substituted triazolo bicyclic compounds as PDE2 inhibitors2019
Factor XIa inhibitors2019
Factor XIA inhibitors2019
Piperazine derivatives as HIV protease inhibitors2018